Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

A Core Proliferative Program Induced By B-Cell Receptor Stimulation in Chronic Lymphocytic Leukemia Cells

Cédric Schleiss, Raphael Carapito, PhD, Luc Mathieu Fornecker, MD PhD, Leslie Muller, Paul Nicodeme, Ouria Tahar, Angélique Pichot, BSc, Laurent Mauvieux, MD PhD, Raoul Herbrecht, MD, Myriam Maumy-Bertrand, Jean-Noel Freund, Christine Carapito, Seiamak Bahram, MD, Frederic Bertrand, Laurent Vallat, MD PhD

Blood (2019) 134 (Supplement_1): 3777.

https://doi.org/10.1182/blood-2019-126779

Published: 2019

Journal Articles

ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown?

Mickaël Martin, MD PhD, Anne Marie Knapp, Dana Ghergus, MD PhD, Fabien Delmotte, Laurent Vallat, MD PhD, Cédric Schleiss, Raoul Herbrecht, MD, Anne-Sophie Korganow, MD PhD, Frédéric Gros, PhD, Sophie Jung, DMD, PhD, Pauline Soulas-Sprauel, PharmD, PhD, Eric Meffre, PhD, Thierry Martin, MD PhD

Blood (2018) 132 (Supplement 1): 1114.

https://doi.org/10.1182/blood-2018-99-118237

Published: 2018

Journal Articles

A Percentage of Normal B Cells from CLL Patients Express ZAP-70, Which Is Associated with Autoimmunity and Could be Responsible for Arising of Malignant Clone

Dana Ghergus, Anne-Marie Knapp, Fabien Delmotte, Mickael Martin, MD, Sophie Jung, PhD, Jean-Nicolas Schickel, PhD, Bernard Drenou, MD, Raoul Herbrecht, MD, Jean-Louis Pasquali, MD PhD, Anne-Sophie Korganow, MD PhD, Laurent Daniel Vallat, MD PhD, Pauline Soulas-Sprauel, PhD, Eric Meffre, PhD, Thierry Martin, MD PhD

Blood (2017) 130 (Supplement 1): 2988.

https://doi.org/10.1182/blood.V130.Suppl_1.2988.2988

Published: 2017

Journal Articles

Germline Mutations Occurring Outside the Negatively Charged Amino Acid Stretches of the Exon 9 of Calr : A Predisposition to Hematological Malignancies?

Laurent Miguet, PhD, Carine Gervais, MD, Antoine Ittel, PharmD, Eric Jeandidier, MD, Anne Galoisy, PharmD, Caroline Mayeur-Rousse, MD, Laurie Monier, PharmD, Alice Eischen, PharmD, Laurent Daniel Vallat, MD PhD, Mario Ojeda, MD, Bernard Drenou, MD, Shanti Ame, MD, Raoul Herbrecht, MD, Laurent Mauvieux, MD PhD

Blood (2017) 130 (Supplement 1): 1646.

https://doi.org/10.1182/blood.V130.Suppl_1.1646.1646

Published: 2017

Journal Articles

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Qian Shi, PhD, Norbert Schmitz, MD, PhD, Christopher Flowers, MD MS, Fang-Shu Ou, PhD, David Cunningham, Michael Pfreundschuh, MD, John F Seymour, Ulrich Jaeger, Thomas M. Habermann, MD, Corinne Haioun, MD PhD, Hervé Tilly, MD PhD, Herve Ghesquieres, MD PhD, Francesco Merli, Marita Ziepert, Raoul Herbrecht, MD, Jocelyne Flament, MD, Tommy Fu, PhD, Bertrand Coiffier, MD PhD, Daniel Sargent, PhD

Blood (2016) 128 (22): 4196.

https://doi.org/10.1182/blood.V128.22.4196.4196

Published: 2016

Journal Articles

Utility of Progression-Free Survival at 24 Months (PFS24) to Predict Subsequent Outcome for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Enrolled on Randomized Clinical Trials: Findings from a Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 5853 Patients

Blood (2016) 128 (22): 3027.

https://doi.org/10.1182/blood.V128.22.3027.3027

Published: 2016

Journal Articles

Multicentric Analyses of the CD148, CD180, and CD200 Combination for the Diagnosis of Mature B-Cell Neoplasm Using Flow Cytometry

Laurent Miguet, PhD, Luc Fornecker, MD, Marie Wyrwas, Sarah Cianferani, Raoul Herbrecht, MD, Jean-Francois Leseve, Veronique Latger-Cannard, Caroline Mayeur-Rousse, MD, Laurent Mauvieux, MD PhD

Blood (2015) 126 (23): 2662.

https://doi.org/10.1182/blood.V126.23.2662.2662

Published: 2015

Journal Articles

Interest of the CD148, CD180 and CD200 Combination in Flow Cytometry Analyses for Mature B-Cell Neoplasms Diagnosis

Laurent Miguet, PhD, Caroline Mayeur-Rousse, MD, Sarah Lennon, Luc Fornecker, MD, Carine Gervais, MD, Antoine Ittel, PharmD, Anne-Cécile Galoisy, PharmD, Alice Eischen, PharmD, Jean-francois Lesseve, MD, Veronique Latger-Cannard, MD, Raoul Herbrecht, MD, Sarah Cianferani, Laurent Mauvieux, MD PhD

Blood (2014) 124 (21): 5407.

https://doi.org/10.1182/blood.V124.21.5407.5407

Published: 2014

Journal Articles

Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

Andre Goy, MD, Michael E. Williams, MD, ScM, Sevgi Kalayoglu Besisik, MD, Johannes Drach, Radhakrishnan Ramchandren, MD, Michael J. Robertson, MD, Irit Avivi, MD, Jacob M Rowe, MD, Raoul Herbrecht, MD, Achiel Van Hoof, Miklos Egyed, Lei Zhang, Sherri Cicero, Tommy Fu, Carla Heise, PhD, Thomas E Witzig, MD

Blood (2013) 122 (21): 3057.

https://doi.org/10.1182/blood.V122.21.3057.3057

Published: 2013

Journal Articles

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Raoul Herbrecht, MD, Mario Ojeda-Uribe, MD, Daniel Kientz, MD, Alain Bohbot, MD, Olivier Hinschberger, MD, Cecile Fohrer, MD, Kun-Lun Liu, MD, Emilie Remy, Christine Ernst, MD, Laurence Corash, MD, Jean-Pierre Cazenave, MD, PhD

Blood (2013) 122 (21): 4820.

https://doi.org/10.1182/blood.V122.21.4820.4820

Published: 2013

Journal Articles

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

Blood (2012) 120 (21): 2841.

https://doi.org/10.1182/blood.V120.21.2841.2841

Published: 2012

Journal Articles

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

Vincent Ribrag, MD, Serge Koscielny, ph.D., Krimo Bouabdallah, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Gilles Salles, MD, Olivier Casasnovas, Christian Recher, MD, Remy Gressin, MD, Jérome Cornillon, M.D., Raoul Herbrecht, MD, Sylviane Iacobelli, Jacques Bosq, M.D., Bertrand Coiffier, MD, PhD

Blood (2012) 120 (21): 685.

https://doi.org/10.1182/blood.V120.21.685.685

Published: 2012

Journal Articles

Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study

Andre Goy, MD, Rajni Sinha, MD, MRCP, Michael E. Williams, M.D., Sevgi Kalayoglu Besisik, Johannes Drach, Radhakrishnan Ramchandren, MD, Michael J. Robertson, MD, Irit Avivi, MD, Jacob M. Rowe, Raoul Herbrecht, MD, Achiel Van Hoof, Miklos Egyed, MD, PhD, Lei Zhang, MD, Sherri Cicero, Tommy Fu, Thomas E. Witzig, MD

Blood (2012) 120 (21): 905.

https://doi.org/10.1182/blood.V120.21.905.905

Published: 2012

Journal Articles

Flow Cytometry Study of CD148, a Tyrosine Phosphatase Receptor, in 184 Chronic B Cell Malignancies, Reveals a High Expression in Mantle Cell and Marginal Zone Lymphomas.

Laurent Miguet, Luc-Matthieu Fornecker, Estelle Zink, Guillaume Bechade, Raoul Herbrecht, MD, Alain van Dorsselaer, Sarah Sanglier, Laurent Mauvieux, MD, PhD

Blood (2009) 114 (22): 1923.

https://doi.org/10.1182/blood.V114.22.1923.1923

Published: 2009

Journal Articles

Gut Aspergillus Infections in Leukemia and Stem Cell Transplant Patients: A Rare and Unrecognized Disease.

Eyad Kazan, MD, J. Maertens, Raoul Herbrecht, MD, Maja Weisser, MD, Bertrand Gachot, MD, Anne Vekhoff, MD, Denis Caillot, MD, Emmanuel Raffoux, MD, Thierry Fagot, MD, Oumedaly Reman, Francoise Isnard, Catherine Cordonnier, MD

Blood (2009) 114 (22): 2220.

https://doi.org/10.1182/blood.V114.22.2220.2220

Published: 2009

Journal Articles

Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.

Wolfgang Ulrich Knauf, MD, Toshko Lissitchkov, MD, Ali Aldaoud, MD, Anna Liberati, MD, Javier Loscertales, MD, Raoul Herbrecht, MD, Gunnar Juliusson, MD, Gerhard Postner, MD, Liana Gercheva, MD, Stefan Goranov, MD, Martin Becker, MD, Hans-Joerg Fricke, MD, Francoise Huguet, MD, Ilaria Del Giudice, MD, Peter Klein, Karlheinz Merkle, MD, Marco Montillo, MD

Blood (2009) 114 (22): 2367.

https://doi.org/10.1182/blood.V114.22.2367.2367

Published: 2009

Journal Articles

10 Years Follow-up of the GELA LNH98.5 Study, First Randomized Study Comparing R-CHOP to CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma.

Bertrand Coiffier, MD, Christian Gisselbrecht, Andre Bosly, MD, PhD, Raoul Herbrecht, MD, Reda Bouabdallah, MD, Pierre Morel, MD, Eric Van Den Neste, MD, PhD, Dominique Bordessoule, MD, Corinne Haioun, MD, Herve Tilly, MD, Gilles Salles, MD, PhD

Blood (2009) 114 (22): 3741.

https://doi.org/10.1182/blood.V114.22.3741.3741

Published: 2009

Journal Articles

Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.

Blood (2009) 114 (22): 4736.

https://doi.org/10.1182/blood.V114.22.4736.4736

Published: 2009

Journal Articles

Are There Specific Markers in Allografted Patients Blood Predicting GvHD?

Stéphane Ducassou, Thomas Lavaux, PharmD, PhD, Michele Legrain, PhD, Anne- Claire Voegeli, PharmD, Aurelia Nguyen, MD, Nadine Cojean, MD, Bruno Lioure, MD, Karin Bilger, MD, Raoul Herbrecht, MD, Patrick Lutz, MD, Natacha Entz- Werle, MD, PhD

Blood (2008) 112 (11): 4608.

https://doi.org/10.1182/blood.V112.11.4608.4608

Published: 2008

Journal Articles

Mannose-Binding Lectin Deficiency - a Risk Factor for Invasive Aspergillosis in Immunocompromised Patients.

Jonathan Lambourne, MD, BA, MRCP, Dan Agranoff, PhD, FRCP, Aby Buchbinder, MD, Peter F Troke, PhD, Raoul Herbrecht, MD, Jodi Lindsay, BSc, MSc, PhD, Thomas Harrison, MD, MPH, FRCP

Blood (2008) 112 (11): 1465.

https://doi.org/10.1182/blood.V112.11.1465.1465

Published: 2008

NARROW

A Core Proliferative Program Induced By B-Cell Receptor Stimulation in Chronic Lymphocytic Leukemia Cells

ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown?

A Percentage of Normal B Cells from CLL Patients Express ZAP-70, Which Is Associated with Autoimmunity and Could be Responsible for Arising of Malignant Clone

Germline Mutations Occurring Outside the Negatively Charged Amino Acid Stretches of the Exon 9 of Calr : A Predisposition to Hematological Malignancies?

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Multicentric Analyses of the CD148, CD180, and CD200 Combination for the Diagnosis of Mature B-Cell Neoplasm Using Flow Cytometry

Interest of the CD148, CD180 and CD200 Combination in Flow Cytometry Analyses for Mature B-Cell Neoplasms Diagnosis

Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study

Flow Cytometry Study of CD148, a Tyrosine Phosphatase Receptor, in 184 Chronic B Cell Malignancies, Reveals a High Expression in Mantle Cell and Marginal Zone Lymphomas.

Gut Aspergillus Infections in Leukemia and Stem Cell Transplant Patients: A Rare and Unrecognized Disease.

Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.

10 Years Follow-up of the GELA LNH98.5 Study, First Randomized Study Comparing R-CHOP to CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma.

Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.

Are There Specific Markers in Allografted Patients Blood Predicting GvHD?

Mannose-Binding Lectin Deficiency - a Risk Factor for Invasive Aspergillosis in Immunocompromised Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only